Larimar Therapeutics (LRMR) Interest & Investment Income (2014 - 2020)

Larimar Therapeutics (LRMR) has reported Interest & Investment Income for 7 consecutive years, with $258000.0 the latest figure, recorded in Q1 2020.

• For the quarter ending Q1 2020, Interest & Investment Income fell 59.81% year-over-year to $258000.0; the trailing twelve-month figure through Mar 2020 stood at $1.6 million (down 29.11% YoY), and the FY2019 full-year result was $2.0 million, up 5.29% from the prior year.
• Interest & Investment Income declined to $258000.0 in Q1 2020 per LRMR's latest filing, from $335000.0 in the prior quarter.
• Across five years, Interest & Investment Income topped out at $675000.0 in Q4 2018 and bottomed at $209000.0 in Q1 2016.
• Historically, Interest & Investment Income has averaged $354470.6 across 5 years, with a median of $266000.0 in 2017.
• The sharpest annual moves came in 2016 and 2020: Interest & Investment Income jumped 435.9% in 2016, then tumbled 59.81% in 2020.
• Over 5 years, Interest & Investment Income stood at $230000.0 in 2016, then rose by 11.3% to $256000.0 in 2017, then surged by 163.67% to $675000.0 in 2018, then sank by 50.37% to $335000.0 in 2019, then retreated by 22.99% to $258000.0 in 2020.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $258000.0, $335000.0, and $451000.0 for Q1 2020, Q4 2019, and Q3 2019 respectively.